MRNA-enhanced cell therapy and cardiovascular regeneration

Palas K. Chanda, Roman Sukhovershin, John P. Cooke

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


mRNA has emerged as an important biomolecule in the global call for the development of therapies during the COVID-19 pandemic. Synthetic in vitro-transcribed (IVT) mRNA can be engineered to mimic naturally occurring mRNA and can be used as a tool to target “undruggable” diseases. Recent advancement in the field of RNA therapeutics have addressed the challenges inherent to this drug molecule and this approach is now being applied to several therapeutic modalities, from cancer immunotherapy to vaccine development. In this review, we discussed the use of mRNA for stem cell generation or enhancement for the purpose of cardiovascular regeneration.

Original languageEnglish (US)
Article number187
Pages (from-to)1-13
Number of pages13
Issue number1
StatePublished - Jan 2021


  • RNA therapeutics
  • cardiovascular ageing
  • cardiovascular regeneration
  • cell therapy
  • iPSCs
  • inflammatory signaling
  • nuclear reprogramming
  • transdifferentiation
  • Cell therapy
  • Nuclear reprogramming
  • Cardiovascular ageing
  • IPSCs
  • Transdifferentiation
  • Inflammatory signaling
  • Cardiovascular regeneration

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'MRNA-enhanced cell therapy and cardiovascular regeneration'. Together they form a unique fingerprint.

Cite this